Search

200 patients diagnosed with breast cancer were analyzed over a period of 5 years (January 2007 to January 2012) who were diagnosed, treated breast specialist at the Department of Oncology, University Hospital of Sancti Spiritus consultation. Prognostic factors related to the primary tumor, presence of metastatic lymph nodes, the treatment performed, the disease-free time and survival time were studied. The prevalence of patients aged 60 and older, with more frequent location in the left breast, and the upper-outer quadrant was found in our series was the most affected breast site. The most important and significant in terms of disease free survival time and prognostic factors were tumor size, nodal status, periganglionar infiltration and determining hormone dependency. It was shown that increasing the size of the primary tumor (T) and regional lymph node involvement (N), the more advanced clinical stage and axillary lymph node metastases in the surgical specimen condition exists greater chance of tumor recurrence occurs with an increased likelihood of distant metastasis and death occurs in these patients incidence. [ABSTRACT FROM AUTHOR]

A descriptive cross-sectional study, retrospective concerning the behavior of neutropenia associated with chemotherapy in solid tumors in the period January 2009-2013 treated at the oncology department of the University General Hospital Camilo Cienfuegos province of Sancti Spiritus was performed. The population was 230 neutropenic patients associated with chemotherapy. Research generally describes the relationship between neutropenia with chemotherapy, tumor location, disease entities associated, age, sex, chemotherapy treatments and antibiotics more used. It was observed that there is a high incidence of neutropenia associated with chemotherapy in patients with lung cancer, the most affected group were 50-59 years of age predominating females with a high rate of associated hypertension. The most commonly used treatments were etoposide-platinum and Ceftrixone-amikacin. [ABSTRACT FROM AUTHOR]